Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Rene Duarte Hernandez

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Vaccines|February 26, 2022
High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density BioreactorAnna Offersgaard, Carlos Rene Duarte Hernandez, Anne Finne Pihl, et al.
Plos Pathogens|May 13, 2026
Collectin-11, a complement pattern recognition molecule, mediates pulmonary SARS-CoV-2 neutralization and protectionAdrian Sutta, Anna Offersgaard, Carlos Rene Duarte Hernandez, et al.
Viruses|September 28, 2023
Substitutions in SARS-CoV-2 Mpro Selected by Protease Inhibitor Boceprevir Confer Resistance to NirmatrelvirKaren Anbro Gammeltoft, Yuyong Zhou, Line Abildgaard Ryberg, et al.
Gut|August 2, 2022
Inactivated genotype 1a, 2a and 3a HCV vaccine candidates induced broadly neutralising antibodies in miceGarazi Pena Alzua, Anne Finne Pihl, Anna Offersgaard, et al.
Vaccines|July 2, 2021
SARS-CoV-2 Production in a Scalable High Cell Density BioreactorAnna Offersgaard, Carlos Rene Duarte Hernandez, Anne Finne Pihl, et al.
Science Advances|December 21, 2022
Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture systemYuyong Zhou, Karen Anbro Gammeltoft, Line Abildgaard Ryberg, et al.
Iscience|January 16, 2023
An inactivated SARS-CoV-2 vaccine induced cross-neutralizing persisting antibodies and protected against challenge in small animalsAnna Offersgaard, Carlos Rene Duarte Hernandez, Shan Feng, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Vaccines|February 26, 2022
High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density BioreactorAnna Offersgaard, Carlos Rene Duarte Hernandez, Anne Finne Pihl, et al.
Plos Pathogens|May 13, 2026
Collectin-11, a complement pattern recognition molecule, mediates pulmonary SARS-CoV-2 neutralization and protectionAdrian Sutta, Anna Offersgaard, Carlos Rene Duarte Hernandez, et al.
Viruses|September 28, 2023
Substitutions in SARS-CoV-2 Mpro Selected by Protease Inhibitor Boceprevir Confer Resistance to NirmatrelvirKaren Anbro Gammeltoft, Yuyong Zhou, Line Abildgaard Ryberg, et al.
Gut|August 2, 2022
Inactivated genotype 1a, 2a and 3a HCV vaccine candidates induced broadly neutralising antibodies in miceGarazi Pena Alzua, Anne Finne Pihl, Anna Offersgaard, et al.
Vaccines|July 2, 2021
SARS-CoV-2 Production in a Scalable High Cell Density BioreactorAnna Offersgaard, Carlos Rene Duarte Hernandez, Anne Finne Pihl, et al.
Science Advances|December 21, 2022
Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture systemYuyong Zhou, Karen Anbro Gammeltoft, Line Abildgaard Ryberg, et al.
Iscience|January 16, 2023
An inactivated SARS-CoV-2 vaccine induced cross-neutralizing persisting antibodies and protected against challenge in small animalsAnna Offersgaard, Carlos Rene Duarte Hernandez, Shan Feng, et al.
Pageof 1